117 related articles for article (PubMed ID: 6086368)
1. Pulmonary blastoma: remission with chemotherapy.
Nissen MH; Jacobsen M; Vindeløv L; Olsen J; Rørth M
Eur J Respir Dis; 1984 Jul; 65(5):377-9. PubMed ID: 6086368
[TBL] [Abstract][Full Text] [Related]
2. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372
[TBL] [Abstract][Full Text] [Related]
3. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
Behera D; Jindal SK; Sharma SC
Indian J Chest Dis Allied Sci; 1995; 37(1):15-9. PubMed ID: 16892733
[TBL] [Abstract][Full Text] [Related]
4. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
Horvath LG; McCaughan BC; Stockle M; Boyer MJ
Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
[TBL] [Abstract][Full Text] [Related]
5. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
Daly BD; Fernando HC; Ketchedjian A; Dipetrillo TA; Kachnic LA; Morelli DM; Shemin RJ
Ann Thorac Surg; 2006 Jul; 82(1):227-31. PubMed ID: 16798219
[TBL] [Abstract][Full Text] [Related]
6. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
7. Case report: pulmonary blastoma in children--response to chemotherapy.
Lobo-Sanahuja F; García I; Santamaría S; Barrantes JC
Med Pediatr Oncol; 1996 Mar; 26(3):196-200. PubMed ID: 8544803
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of microcytic carcinoma of the lung with vincristine, adriamycin, cyclophosphamide and VP-16].
Sangro Gómez-Acebo B; Díaz-Rubio García E; Martín Jiménez M; González Larriba JL; Vila Borrajo C
Rev Clin Esp; 1986 Oct; 179(6):296-301. PubMed ID: 3025943
[No Abstract] [Full Text] [Related]
9. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of surgical resection of pulmonary metastasis of trophoblastic tumour].
Ren T; Xiang Y; Yang XY; Wan XR; Zhang ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):418-21. PubMed ID: 12974086
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of stage III lung cancer after chemotherapy and radiotherapy.
Lee DY; Kim HK; Paik HC; Kim HJ; Kim SJ
Jpn J Clin Oncol; 1994 Apr; 24(2):101-5. PubMed ID: 8158856
[TBL] [Abstract][Full Text] [Related]
13. [A combination chemotherapy consisting of vincristine, etoposide and cyclophosphamide (VEC) for small cell carcinoma of the lung].
Adachi K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Nakata H; Tada A; Aiba K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1617-22. PubMed ID: 6089668
[TBL] [Abstract][Full Text] [Related]
14. [Malignant lymphoma following operation and chemotherapy of small cell lung carcinoma].
Yokoi M; Nagai T; Hirabayashi M; Okamura A; Tatsumi E; Nishikori M
Rinsho Ketsueki; 1993 Mar; 34(3):378-80. PubMed ID: 8386780
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study and treatment result of small cell lung carcinoma using combination chemotherapy].
Mei QD; Yan M; Huang XL
Zhonghua Zhong Liu Za Zhi; 1994 Jan; 16(1):43-6. PubMed ID: 8033748
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT).
Mulder NH; Meinesz AF; Sleijfer DT; Postmus PE; De Vries EG; Van der Geest S; Orie JL; Vriesendorp R
Neth J Med; 1984; 27(10):389-92. PubMed ID: 6096742
[No Abstract] [Full Text] [Related]
17. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients.
Xu G; Rong T; Lin P
Chin Med J (Engl); 2000 Jul; 113(7):617-20. PubMed ID: 11776031
[TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ
Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380
[TBL] [Abstract][Full Text] [Related]
20. Role of chemotherapy in pediatric pulmonary blastoma.
Ozkaynak MF; Ortega JA; Laug W; Gilsanz V; Isaacs H
Med Pediatr Oncol; 1990; 18(1):53-6. PubMed ID: 2152957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
